2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.
Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.
The Internal Revenue Service’s Criminal Investigation unit has a new initiative for engaging with financial institutions to uncover tax and financial fraud.
The Securities and Exchange Commission voted to end its defense of the climate-related disclosure rule it approved last year under the Biden administration.